Nervgen Pharma NGEN
NASDAQ NGEN
$1.44 +0.09 (+6.67%)
As of: Nov 12, 2026 · 1:12 PM EST

Nervgen Pharma (NGEN) Interest & Investment Income (2025 - 2026)

Updated

Nervgen Pharma (NGEN) recorded Interest & Investment Income of -$130,452 in Q2 2026, compared with -$62,720 a year earlier.

Analysis

Nervgen Pharma (NGEN) Interest & Investment Income (2025 - 2026) Analysis & Trends

On a TTM basis, Nervgen Pharma's Interest & Investment Income came in at -$193,957 as of Jun 30, 2026; for FY2025, it was $238,632, down 59.8% from FY2024.

  • Across earlier years, Interest & Investment Income came in at $593,535 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 186.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 67.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Nervgen Pharma 105.93 Mn 4.82 Mn - -130,451.87
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -130,451.87
Mar 31, 2026 -75,886.25
Jun 30, 2025 -62,719.70
Mar 31, 2025 -75,100.42
API Access

Nervgen Pharma Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NGEN&period=max&api_key=YOUR_API_KEY